Related Experiment Video
Updated: Jun 27, 2025

10:14
Expression and Purification of Nuclease-Free Oxygen Scavenger Protocatechuate 3,4-Dioxygenase
Published on: November 8, 2019
6.3K
Layered Double Hydroxide-Based PdCux@LDH Alloy Nanozyme for a Singlet Oxygen-Boosted Sonodynamic Therapy
Minli Mo1, Yashuo Jiang1, Aichun Kang2
1School of Science, China University of Geosciences (Beijing), Beijing 100083, P. R. China.
ACS Applied Materials & Interfaces
|April 29, 2024
Summary
This study introduces PdCu@LDH nanoalloys for enhanced cancer therapy. Ultrasound stimulation boosts their activity, generating reactive oxygen species to disrupt cancer cells via sonodynamic therapy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Redox nanozymes show promise for cancer therapy but face challenges in complex tumor microenvironments.
- Palladium nanocrystals and noble metal nanoalloys offer tunable enzymatic activity and enhanced catalytic properties.
Purpose of the Study:
- To design and synthesize bimetallic nanoalloys (PdCu@LDH) with optimized enzymatic activity for ultrasound-improved cancer therapy.
- To investigate the multienzyme-mimicking activities and reactive oxygen species (ROS) generation of PdCu@LDH under ultrasound stimulation.
Main Methods:
- Design and synthesis of PdCu@LDH bimetallic nanoalloys.
- Evaluation of singlet oxygen (¹O₂) production efficiency and selectivity.
- Assessment of oxidase (OXD) and catalase (CAT)-mimicking activities.
- Investigation of ultrasound (US) stimulation effects on nanozyme activity and ROS generation.
Main Results:
- PdCu@LDH nanoalloys efficiently produce long-lived singlet oxygen (¹O₂) for cancer therapy.
- The nanozyme exhibits surface-dependent dual-enzyme-mimicking activities (OXD and CAT).
- Ultrasound stimulation enhances these activities, leading to increased ROS generation, NADH consumption, and mitochondrial dysfunction.
Conclusions:
- PdCu@LDH nanoalloys are effective for ultrasound-improved cancer therapy by generating ROS and inducing mitochondrial dysfunction.
- This work presents a new strategy for applying nanozymes in sonodynamic therapies (SDT).

